Consun Pharmaceutical Group Limited (FRA:C1P)
1.580
-0.010 (-0.63%)
At close: Dec 5, 2025
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| Consun Pharmaceutical | 2.74B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Consun Pharmaceutical Growth | 13.16% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Yulin Pharmaceutical | 472.41M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Yulin Pharmaceutical Growth | 8.22% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Kidney Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Kidney Medicines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gynaecology and Paediatrics Drugs | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Gynaecology and Paediatrics Drugs Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contrast Medium | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Contrast Medium Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedics Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Orthopedics Medicines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatologic Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Dermatologic Medicines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Medicines | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Hepatobiliary Medicines Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | NaN - NaN |
|---|---|---|---|---|---|---|
| China | 3.22B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | 12.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|